The Asia Pacific Dental Cartridge Syringe Market would witness market growth of 5.7% CAGR during the forecast period (2023-2031). In the year 2022, the Asia Pacific market's volume surged to 1,875.1 thousand units, showcasing a growth of 16.4% (2020-2023).
Aspirating dental syringes play a crucial role in the market, offering precision and safety in administering local anesthesia during dental procedures. These syringes feature a mechanism that allows the dentist to aspirate before injecting the anesthetic solution, ensuring the needle tip is not within a blood vessel, thus reducing the risk of intravascular injection and potential complications. Therefore, the Japan market make use of 230.0 thousand units of Aspirating dental syringes in the market in 2023.
The China market dominated the Asia Pacific Dental Cartridge Syringe Market by Country in 2023, and would continue to be a dominant market till 2031; thereby, achieving a market value of $12,648.9 Thousands by 2031. The Japan market is registering a CAGR of 5% during (2024 - 2031). Additionally, The India market would showcase a CAGR of 6.3% during (2024 - 2031).
Multiple studies have demonstrated the connection between chronic diseases and oral health. An investigation published in July 2022 in the National Library of Medicine proposed that individuals with multimorbidity exhibited a greater incidence of edentulous conditions. Moreover, as per data released by the National Institute of Dental and Craniofacial Research, individuals diagnosed with diabetes face an elevated susceptibility to periodontal diseases due to its detrimental impact on the immune system, compromised healing process, and potential repercussions on dental treatment.
Tobacco use, alcohol consumption, an unhealthy diet high in free sugars, and other modifiable risk factors are prevalent in the majority of oral diseases and conditions, as well as in the four leading noncommunicable diseases (cancer, cardiovascular disease, diabetes, and chronic respiratory disease). Furthermore, there exists a reciprocal association between diabetes and both the onset and advancement of periodontal disease. An elevated intake of sugar is additionally associated with the development of obesity, diabetes, and dental caries.
According to the International Trade Administration (ITA), the People's Republic of China is the second-largest healthcare sector globally. Medical devices are a significant sales sector for international companies in the healthcare industry, especially for technologically advanced and high-end medical devices. Public institutions continue to be the primary purchasers of medical devices in China. According to data from the National Health Commission's website, China had 36,570 hospitals by 2021, accommodating 3,88 billion patient visits. Public facilities accounted for 84.2% of patient visits. Thus, the regional market is expanding due to the expanding healthcare sector and developing medical infrastructure in the region.
Based on Product Type, the market is segmented into Non-disposable and Disposable. Based on Type, the market is segmented into Aspirating, Non-Aspirating and Self-Aspirating. Based on End User, the market is segmented into Dental Clinics, Hospital and Others. Based on countries, the market is segmented into China, Japan, India, South Korea, Australia, Malaysia, and Rest of Asia Pacific.
Aspirating dental syringes play a crucial role in the market, offering precision and safety in administering local anesthesia during dental procedures. These syringes feature a mechanism that allows the dentist to aspirate before injecting the anesthetic solution, ensuring the needle tip is not within a blood vessel, thus reducing the risk of intravascular injection and potential complications. Therefore, the Japan market make use of 230.0 thousand units of Aspirating dental syringes in the market in 2023.
The China market dominated the Asia Pacific Dental Cartridge Syringe Market by Country in 2023, and would continue to be a dominant market till 2031; thereby, achieving a market value of $12,648.9 Thousands by 2031. The Japan market is registering a CAGR of 5% during (2024 - 2031). Additionally, The India market would showcase a CAGR of 6.3% during (2024 - 2031).
Multiple studies have demonstrated the connection between chronic diseases and oral health. An investigation published in July 2022 in the National Library of Medicine proposed that individuals with multimorbidity exhibited a greater incidence of edentulous conditions. Moreover, as per data released by the National Institute of Dental and Craniofacial Research, individuals diagnosed with diabetes face an elevated susceptibility to periodontal diseases due to its detrimental impact on the immune system, compromised healing process, and potential repercussions on dental treatment.
Tobacco use, alcohol consumption, an unhealthy diet high in free sugars, and other modifiable risk factors are prevalent in the majority of oral diseases and conditions, as well as in the four leading noncommunicable diseases (cancer, cardiovascular disease, diabetes, and chronic respiratory disease). Furthermore, there exists a reciprocal association between diabetes and both the onset and advancement of periodontal disease. An elevated intake of sugar is additionally associated with the development of obesity, diabetes, and dental caries.
According to the International Trade Administration (ITA), the People's Republic of China is the second-largest healthcare sector globally. Medical devices are a significant sales sector for international companies in the healthcare industry, especially for technologically advanced and high-end medical devices. Public institutions continue to be the primary purchasers of medical devices in China. According to data from the National Health Commission's website, China had 36,570 hospitals by 2021, accommodating 3,88 billion patient visits. Public facilities accounted for 84.2% of patient visits. Thus, the regional market is expanding due to the expanding healthcare sector and developing medical infrastructure in the region.
Based on Product Type, the market is segmented into Non-disposable and Disposable. Based on Type, the market is segmented into Aspirating, Non-Aspirating and Self-Aspirating. Based on End User, the market is segmented into Dental Clinics, Hospital and Others. Based on countries, the market is segmented into China, Japan, India, South Korea, Australia, Malaysia, and Rest of Asia Pacific.
List of Key Companies Profiled
- STERIS PLC
- Jalal Surgical
- B.Braun SE
- Integra LifeSciences Holdings Corporation
- Henke Sass Wolf GmbH
- Lifco AB (Carl Bennet AB)
- Vista Apex
- AR Instrumed Pty Ltd
- Septodont Holding SAS
- Snaa Industries
Market Report Segmentation
By Product Type (Volume, Thousand Units, USD Million, 2020-2031)- Non-disposable
- Disposable
- Aspirating
- Non-Aspirating
- Self-Aspirating
- Dental Clinics
- Hospital
- Others
- China
- Japan
- India
- South Korea
- Australia
- Malaysia
- Rest of Asia Pacific
Table of Contents
Chapter 1. Market Scope & Methodology
Chapter 2. Market at a Glance
Chapter 3. Market Overview
Chapter 4. Asia Pacific Dental Cartridge Syringe Market by Product Type
Chapter 5. Asia Pacific Dental Cartridge Syringe Market by Type
Chapter 6. Asia Pacific Dental Cartridge Syringe Market by End User
Chapter 7. Asia Pacific Dental Cartridge Syringe Market by Country
Chapter 8. Company Profiles
Companies Mentioned
- STERIS PLC
- Jalal Surgical
- B. Braun SE
- Integra LifeSciences Holdings Corporation
- Henke Sass Wolf GmbH
- Lifco AB (Carl Bennet AB)
- Vista Apex
- AR Instrumed Pty Ltd
- Septodont Holding SAS
- Snaa Industries
Methodology
LOADING...
